Companies
About Us
Philogen is a fully-integrated Swiss-Italian biotechnology company founded in 1996 with a mission to innovate the treatment of cancer and other serious conditions. The company is listed on the Italian Stock Exchange.
Philogen’s strategy is to deliver bioactive agents to the site of disease using antibodies, thus increasing the therapeutic activity and helping spare normal tissues. The company has generated a strong proprietary pipeline of clinical-stage products.